Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Addex Therapeutics (ADXN) Interest Expenses (2022 - 2025)

Historic Interest Expenses for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$1021.3.

  • Addex Therapeutics' Interest Expenses rose 9258.1% to -$1021.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $4066.3, marking a year-over-year decrease of 9919.37%. This contributed to the annual value of $4031.9 for FY2024, which is 9887.25% down from last year.
  • As of Q3 2025, Addex Therapeutics' Interest Expenses stood at -$1021.3, which was up 9258.1% from $7039.6 recorded in Q2 2025.
  • In the past 5 years, Addex Therapeutics' Interest Expenses ranged from a high of $519764.5 in Q4 2023 and a low of -$154106.4 during Q2 2023
  • Moreover, its 4-year median value for Interest Expenses was -$700.01 (2024), whereas its average is $46308.9.
  • The largest annual percentage gain for Addex Therapeutics' Interest Expenses in the last 5 years was 83681.63% (2025), contrasted with its biggest fall of 294274.76% (2025).
  • Quarter analysis of 4 years shows Addex Therapeutics' Interest Expenses stood at $443297.6 in 2022, then increased by 17.25% to $519764.5 in 2023, then crashed by 96.28% to $19347.7 in 2024, then crashed by 105.28% to -$1021.3 in 2025.
  • Its Interest Expenses stands at -$1021.3 for Q3 2025, versus $7039.6 for Q2 2025 and -$21299.6 for Q1 2025.